SCHEMBL9014669

SCHEMBL9014669

COC(=O)c1ccc(C(C)C)c(S(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
CYP1A2 P05177 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
NOTUM Q6P988 2/20 0.43
SLC9A1 P19634 2/20 0.43
SLC9A2 Q9UBY0 1/20 0.42
ALDH1A1 P00352 5/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
XDH P47989 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
VCAM1 P19320 1/20 0.40
KDM4E B2RXH2 6/20 0.40
PDK2 Q15119 4/20 0.40
PDK1 Q15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659788 0.84 ACE2 (0.47) SMN1; SMN2CYP1A2SLC9A1SLC9A2KDM4E
SCHEMBL31498196 0.84 NOTUM (0.49) SMN1; SMN2CYP1A2TSHRCYP2C19NOTUM
SCHEMBL31498198 0.81 CA12 (0.56) SMN1; SMN2CYP1A2TSHRCYP2C19NOTUM
SCHEMBL9014825 0.80 NOTUM (0.56) SMN1; SMN2CYP1A2TSHRCYP2C19NOTUM
SCHEMBL17593784 0.80 ALDH1A1 (0.50) SMN1; SMN2CYP1A2TSHRCYP2C19NOTUM
SCHEMBL8647598 0.78 SLC9A1 (0.44) SLC9A1SLC9A2CA1CA2LMNA
SCHEMBL8647605 0.77 SLC9A1 (0.72) SLC9A1SLC9A2
SCHEMBL3903297 0.77 NOTUM (0.59) SMN1; SMN2NOTUMALDH1A1L3MBTL1CA12
SCHEMBL13220716 0.75 CA1 (0.53) SMN1; SMN2TSHRALDH1A1CA12CA1
SCHEMBL14159036 0.75 CA1 (0.46) SMN1; SMN2NOTUMALDH1A1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571842-A ANTIARRHYTHMIA AND ANTIISCHEMIC AGENTS, DIAGNOSIS OF CANCER AND HYPERTENSION HOECHST AKTIENGESELLSCHAFT (DE) 1996-11-05 US disclosed